David Platt - Aug 21, 2023 Form 4 Insider Report for BIOXYTRAN, INC (BIXT)

Role
CEO, Director, 10%+ Owner
Signature
David Platt
Stock symbol
BIXT
Transactions as of
Aug 21, 2023
Transactions value $
$160,000
Form type
4
Date filed
8/24/2023, 03:15 PM
Previous filing
May 17, 2023
Next filing
Sep 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIXT common stock Gift $160K +500K +5.12% $0.32 10.3M Aug 21, 2023 by NDPD Pharma, Inc. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The total holdings in BIXT by NDPD Pharma, Inc., partly owned by officers of BIXT, are consolidated under indirect ownership in Davis Platt's filing.